Covid-19 Effects on ARTErial StIffness and Vascular AgiNg
Status: Recruiting
Location: See all (3) locations...
Intervention Type: Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The purpose of the study is to evaluate the presence of early vascular aging 6 months and 12 months after COVID-19 infection.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:
• age \>18 years, both sexes;
• written informed consent;
• affiliation to a social security regime;
• a recent diagnosis of COVID19 (6±3 months) proven by PCR or serology (for group 1,2,3)
• hospitalization in intensive care unit for COVID19 (for group 1)
• hospitalization in a medicine unit for COVID19 (for group 2)
• no hospitalization for COVID19 or hospitalization less than 24h (for group 3)
• a negative test for SARS-nCOV2 infection (PCR or serology)(for group 4)
Locations
Other Locations
France
CHRU Nancy
RECRUITING
Nancy
Hôpital Européen Georges Pompidou - APHP
RECRUITING
Paris
CHU Rouen
RECRUITING
Rouen
Contact Information
Primary
Rosa Maria BRUNO, MD
rosa-maria.bruno@inserm.fr
+33 1 53 98 79 67
Backup
Laura LE MAO, MSc
laura.le-mao@aphp.fr
+33 1 56 09 54 97
Time Frame
Start Date: 2020-09-21
Estimated Completion Date: 2033-03
Participants
Target number of participants: 360
Treatments
Other: Group 1
Patients with confirmed infection by SARS-Cov-2, requiring a hospitalization in intensive care unit
Other: Group 2
Patients with confirmed infection by SARS-Cov-2, requiring a hospitalization in a medicine unit
Other: Group 3
Patients with confirmed infection by SARS-Cov-2, not requiring hospitalization
Other: Group 4
4\) individuals having performed a test for SARS-Cov-2 infection, but resulted to be negative
Related Therapeutic Areas
Sponsors
Collaborators: Institut National de la Santé Et de la Recherche Médicale, France, The Association for Research into Arterial Structure and Physiology
Leads: Assistance Publique - Hôpitaux de Paris